RESOLVE 2024 Concludes with Impactful Sessions on Complex and Pressing Issues Shaping Global Dispute Resolution
ABU DHABI, UAE, Dec. 11, 2024 /PRNewswire/ -- The highly anticipated RESOLVE 2024,…
RESOLVE 2024 Concludes with Impactful Sessions on Complex and Pressing Issues Shaping Global Dispute Resolution
ABU DHABI, UAE, Dec. 11, 2024 /PRNewswire/ -- The highly anticipated RESOLVE 2024,…
Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024
Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen…
Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific Sessions
Allschwil, Switzerland – November 11, 2024 Idorsia Ltd (SIX: IDIA) today announced…